pharma · Inguinal Hernia
Second Hospital of
Second Hospital of Jilin University
Second Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Inguinal Hernia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this enti
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Hydromorphone combined with ropivacaine
Unknown · small molecule · Inguinal Hernia
Hydromorphone combined with ropivacaine for Inguinal Hernia is a Unknown program (small_molecule) at Second Hospital of Jilin University with 1 ClinicalTrials.gov record(s).
Internal code 2022/148
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Second Hospital of Jilin University
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Inguinal Hernia
- Status
- completed
- Trials
- 1